Executive record

Robert A. Berman

Director at enVVeno Medical Corp

Alpha ID: alpha:person:robert-a-bermanVersion: public-0As of: 2026-09-30

Not yet claimed19 published Claims11 sources

Director

Key Claims

Biography

Over 25 years of experience in healthcare, finance, acquisitions, marketing, compliance, turnarounds, and development and licensing of emerging technologies. Previously served as President, CEO and Board member of ITUS Corporation (now Anixa Biosciences) and Chief Operating Officer and General Counsel of Acacia Research Corporation.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

enVVeno Medical Corp

Current

Director 2018 to present

View company profile

Rekor Systems, Inc.

Current

Director 2016 to present

View company profile

Claims

Executive career

2026 to end not publishedExecutive title: President and Chief Executive Officer, and Chairman of the Board · Organization not publishedREKR DEF 14A executive officers
2026 to end not publishedExecutive title: Chief Executive Officer · Organization not publishedNVNO 10-K executive officers
2026 to end not publishedExecutive title: Group Executive Vice President, Research and Strategy · Organization not publishedCFR 10-K executive officers
2024 to end not publishedExecutive title: Director · Organization not publishedNMGX 10-K executive officers
Dates not publishedExecutive title: President and Chief Executive Officer · Organization not publishedREKR DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

11 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

REKR DEF 14A executive officers
sec filing · Source published: Apr 1, 2026 · Retrieved: May 16, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Executive company: Executive at Rekor Systems, Inc. · Claim reviewed: May 16, 2026
- Executive title: Executive title: President and Chief Executive Officer, and Chairman of the Board · Claim reviewed: May 16, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026
REKR DEF 14A director slate
sec filing · Source published: Apr 1, 2026 · Retrieved: May 16, 2026
Supports 7 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Board role: Board role: Chair · Claim reviewed: May 16, 2026
- Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 16, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Executive company: Executive at Rekor Systems, Inc. · Claim reviewed: May 16, 2026
- Executive title: Executive title: President and Chief Executive Officer · Claim reviewed: May 16, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026
Open source
sec proxy · Source published: Apr 1, 2026 · Retrieved: Apr 24, 2026
Supports 1 claim
- Professional Role: Director at Rekor Systems, Inc. · Claim reviewed: May 16, 2026
NVNO 10-K executive officers
sec filing · Source published: Mar 26, 2026 · Retrieved: May 16, 2026
Supports 2 claims
- Executive company: Executive at enVVeno Medical Corp · Claim reviewed: May 16, 2026
- Executive title: Executive title: Chief Executive Officer · Claim reviewed: May 16, 2026
CFR 10-K executive officers
sec filing · Source published: Feb 5, 2026 · Retrieved: May 16, 2026
Supports 2 claims
- Executive company: Executive at CULLEN/FROST BANKERS, INC. · Claim reviewed: Jul 28, 2026
- Executive title: Executive title: Group Executive Vice President, Research and Strategy · Claim reviewed: Jul 28, 2026
CFR-PB 10-K executive officers
sec filing · Source published: Feb 5, 2026 · Retrieved: Jul 28, 2026
Supports 2 claims
- Executive company: Executive at CULLEN/FROST BANKERS, INC. · Claim reviewed: Jul 28, 2026
- Executive title: Executive title: Group Executive Vice President, Research and Strategy · Claim reviewed: Jul 28, 2026
NVNO DEF 14A director slate
sec filing · Source published: Oct 30, 2025 · Retrieved: May 16, 2026
Supports 2 claims
- Board role: Board role: Director · Claim reviewed: May 16, 2026
- Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 16, 2026
Open source
sec proxy · Source published: Oct 30, 2025 · Retrieved: Apr 28, 2026
Supports 1 claim
- Professional Role: Director at enVVeno Medical Corp · Claim reviewed: May 16, 2026
NMGX 10-K executive officers
sec filing · Source published: Apr 3, 2024 · Retrieved: May 16, 2026
Supports 2 claims
- Executive company: Executive at Nano Magic Inc. · Claim reviewed: May 16, 2026
- Executive title: Executive title: Director · Claim reviewed: May 16, 2026
Open source
public source · Source published: Date unavailable · Retrieved: Date unavailable
Supports 1 claim
- Board membership: Serves on the board of enVVeno Medical Corp · Claim reviewed: May 16, 2026
Open source
public source · Source published: Date unavailable · Retrieved: Date unavailable
Supports 1 claim
- Board membership: Serves on the board of Rekor Systems, Inc. · Claim reviewed: May 16, 2026